K. Geoghegan-Barek

Co-administration of a CpG adjuvant (VaxImmuneTM, CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice

L. Thomas, R. Hammond, Eric M. Forsberg, 2009, Human vaccines.

A cell-based high-throughput screen identifies tyrphostin AG 879 as an inhibitor of animal cell phospholipid and fatty acid biosynthesis

R. Zoeller, K. Geoghegan-Barek, 2019, Biochemistry and biophysics reports.

Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization

A. Barabasi, S. Elledge, M. Zitnik, 2022, iScience.

Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo

A. Barabasi, S. Elledge, M. Zitnik, 2022, bioRxiv.

Recombinant Glycoproteins That Inhibit Complement Activation and Also Bind the Selectin Adhesion Molecules*

A. C. Sen, V. Reinhold, G. Hannig, 1999, The Journal of Biological Chemistry.

Microtubule disassembly induced by sensitizing halogenated nitrobenzene derivatives.

I. Chou, M. Leung, K. Geoghegan-Barek, 1990, Toxicology in vitro : an international journal published in association with BIBRA.

Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo

A. Barabasi, M. Zitnik, J. Loscalzo, 2021, bioRxiv.